APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES
申请人:AbbVie Inc.
公开号:US20140088106A1
公开(公告)日:2014-03-27
Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein.
本发明揭示了一种抑制抗凋亡Bcl-2蛋白活性的化合物,包含该化合物的组合物以及治疗在其中表达抗凋亡Bcl-2蛋白的疾病的方法。